CN106727618A - 复方磺胺甲噁唑口服混悬剂及其制备方法 - Google Patents
复方磺胺甲噁唑口服混悬剂及其制备方法 Download PDFInfo
- Publication number
- CN106727618A CN106727618A CN201710000282.9A CN201710000282A CN106727618A CN 106727618 A CN106727618 A CN 106727618A CN 201710000282 A CN201710000282 A CN 201710000282A CN 106727618 A CN106727618 A CN 106727618A
- Authority
- CN
- China
- Prior art keywords
- sodium
- sulfamethoxazole
- oral suspensions
- citric acid
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710000282.9A CN106727618B (zh) | 2017-01-02 | 2017-01-02 | 复方磺胺甲噁唑口服混悬剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710000282.9A CN106727618B (zh) | 2017-01-02 | 2017-01-02 | 复方磺胺甲噁唑口服混悬剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106727618A true CN106727618A (zh) | 2017-05-31 |
CN106727618B CN106727618B (zh) | 2020-01-24 |
Family
ID=58952883
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710000282.9A Active CN106727618B (zh) | 2017-01-02 | 2017-01-02 | 复方磺胺甲噁唑口服混悬剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106727618B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113041219A (zh) * | 2021-03-31 | 2021-06-29 | 南京日升昌生物技术有限公司 | 一种复方磺胺嘧啶混悬液及其制备方法和应用 |
WO2021232614A1 (zh) * | 2020-05-22 | 2021-11-25 | 广东药科大学 | 壳寡糖口服液及其在制备减肥药物中的应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006093784A2 (en) * | 2005-02-25 | 2006-09-08 | Mutual Pharmaceutical Company, Inc. | Dosage forms of antibiotics and combinations of antibiotics ans symptomatic relief agents |
CN1907264A (zh) * | 2006-08-04 | 2007-02-07 | 苏州科牧动物药品有限公司 | 复方磺胺混悬剂及其制备方法 |
CN103405463A (zh) * | 2012-08-06 | 2013-11-27 | 四川联美生物药业有限公司 | 增效酒石酸泰乐菌素可溶性粉的复方药物制备方法 |
-
2017
- 2017-01-02 CN CN201710000282.9A patent/CN106727618B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006093784A2 (en) * | 2005-02-25 | 2006-09-08 | Mutual Pharmaceutical Company, Inc. | Dosage forms of antibiotics and combinations of antibiotics ans symptomatic relief agents |
CN1907264A (zh) * | 2006-08-04 | 2007-02-07 | 苏州科牧动物药品有限公司 | 复方磺胺混悬剂及其制备方法 |
CN103405463A (zh) * | 2012-08-06 | 2013-11-27 | 四川联美生物药业有限公司 | 增效酒石酸泰乐菌素可溶性粉的复方药物制备方法 |
Non-Patent Citations (1)
Title |
---|
丁建等: "高效液相色谱法测定复方磺胺甲噁唑混悬剂的含量", 《江苏药学与临床研究》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021232614A1 (zh) * | 2020-05-22 | 2021-11-25 | 广东药科大学 | 壳寡糖口服液及其在制备减肥药物中的应用 |
CN113041219A (zh) * | 2021-03-31 | 2021-06-29 | 南京日升昌生物技术有限公司 | 一种复方磺胺嘧啶混悬液及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN106727618B (zh) | 2020-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW442295B (en) | Stable freeze-dried pharmaceutical composition | |
JP2002524398A (ja) | 安定化二部型消毒系ならびにそれに関連した組成物および方法 | |
JP5108517B2 (ja) | 治療活性剤、クエン酸または共役塩基、および二酸化塩素を含む安定化された組成物 | |
CN104161752B (zh) | 一种维格列汀组合物 | |
US20130095146A1 (en) | Ciclesonide containing aqueous pharmaceutical composition | |
CN106727618A (zh) | 复方磺胺甲噁唑口服混悬剂及其制备方法 | |
CN107304212A (zh) | 一种无定型l-5-甲基四氢叶酸氨基酸盐及其制备方法 | |
CN105534894A (zh) | 一种触变型抗球虫混悬剂及其制备方法 | |
CN102860980A (zh) | 一种罗库溴铵注射液的制备方法 | |
US20030055109A1 (en) | Stable gabapentin having pH within a controlled range | |
FI81961B (fi) | Foerfarande foer framstaellning av coccidioslaekemedel. | |
US20070213406A1 (en) | Anti-Inflammatory Analgesic External Aqueus Liquid Preparation | |
KR20130114230A (ko) | 고안정성 폴리 비닐 피롤리돈 요오드 용액 및 관련 제조 방법 | |
US6368638B1 (en) | Process of making an aqueous calcium carbonate suspension | |
CN103933033B (zh) | 一种性能改善的甲硝唑氯己定洗剂 | |
TWI246925B (en) | Solution of N-[o-(p-pivaloyloxybenzenesulfonylamino)benzoyl]glycine monosodium salt tetrahydrate, and the medicament thereof | |
CN107823132A (zh) | 一种马波沙星混悬液及其制备方法 | |
CN101172108A (zh) | 普卢利沙星活性体注射剂 | |
CN105395476A (zh) | 盐酸沙拉沙星注射液及其制备方法 | |
CN103735522B (zh) | 一种炎琥宁冻干粉针及其制备方法 | |
CN106478669A (zh) | 一种高纯度盐酸头孢噻呋的精制方法 | |
CN101972257B (zh) | 一种含有莫西沙星的药物组合物 | |
CN104721197A (zh) | 一种含恩诺沙星、磺胺嘧啶银悬浮剂及其制备方法 | |
KR20040085825A (ko) | 비타민c-안정화 액상 조성물 | |
CN108578417A (zh) | 一种复方磺胺氯哒嗪钠干混悬剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Compound sulfamethoxazole oral suspension and its preparation method Effective date of registration: 20211228 Granted publication date: 20200124 Pledgee: Haimen sub branch of Bank of Nanjing Co.,Ltd. Pledgor: JIANGSU HFQ BIO-TECHNOLOGY Co.,Ltd. Registration number: Y2021320010618 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230329 Granted publication date: 20200124 Pledgee: Haimen sub branch of Bank of Nanjing Co.,Ltd. Pledgor: JIANGSU HFQ BIO-TECHNOLOGY Co.,Ltd. Registration number: Y2021320010618 |